Results 191 to 200 of about 108,556 (242)

The role of Choline-PET/CT in patients with recurrent prostate cancer and a negative PSMA-PET/CT. [PDF]

open access: yesEJNMMI Rep
Gözlügöl N   +7 more
europepmc   +1 more source

External Validation of the Martini‐Klinik Nomogram Predicting the Indication for Adjuvant Radiation Therapy According to EAU Guidelines Among Patients With High‐Risk Prostate Cancer After Radical Prostatectomy

open access: yesThe Prostate, EarlyView.
ABSTRACT Objective To externally validate the Martini‐Klinik nomogram based on patient and clinical tumor characteristics predicting the indication for adjuvant radiation therapy after radical prostatectomy according to guideline recommendations of the European Association of Urology (EAU) in high‐risk prostate cancer patients treated with radical ...
Carolin Siech   +12 more
wiley   +1 more source

Does It Make Sense to Perform Prostate Magnetic Resonance Imaging in Men with Normal PSA (<4 ng/mL)? [PDF]

open access: yesCancers (Basel)
De Visschere P   +12 more
europepmc   +1 more source

Metabolomic Insights Into Saliva as a Non‐Invasive Surrogate for Serum to Enable Community‐Based Biomarker Investigation

open access: yesThe Prostate, EarlyView.
ABSTRACT Introduction Using serum metabolomics in Community‐Based Participatory Research (CBPR) with underserved populations presents challenges due to the invasive nature of venipuncture, which limits longitudinal sample collection in community settings. In this pilot study, we compared saliva and serum metabolomics in patients with prostate cancer to
Alireza Abdshah   +13 more
wiley   +1 more source

Optimizing Prostate Biopsy Pathways: Integrating MRI-Targeted, Systematic Sampling, and Clinical Judgment in the PSA-Era. [PDF]

open access: yesDiagnostics (Basel)
Bulai CA   +8 more
europepmc   +1 more source

A Pilot Study of 18F‐rhPSMA‐7.3‐PET/MRI to Reduce Mischaracterization of Active Surveillance and Focal Therapy Candidates With Occult Higher Risk Disease

open access: yesThe Prostate, EarlyView.
ABSTRACT Introduction PSMA‐PET offers an opportunity to reduce the mischaracterization of disease in active surveillance (AS) and focal therapy (FT) candidates. We describe the results of a pilot clinical trial evaluating 18F‐radiohybrid(rh)PSMA‐7.3‐PET/MRI to detect occult adverse pathology among potential AS and FT candidates (NCT05852041).
Ridwan Alam   +11 more
wiley   +1 more source

The effect of opium consumption on prostate cancer among Iranian patients: A retrospective analytical study. [PDF]

open access: yesMedicine (Baltimore)
Mohammadi R   +5 more
europepmc   +1 more source

Challenges of Prostatic Tuberculosis: When Infection and Neoplasia Coexist. [PDF]

open access: yesCureus
Sandoval Enriquez KG   +4 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy